Construction of eukaryotic expressing plasmids encodingHA andHA₁ of influenza A virus and their transient expression in HEK293 cells

Abstract

In order to explore the feasibility and protective efficiency of influenza DNA vaccine, we constructed eukaryotic expressing plasmids encodingHA andHA₁ of influenza A virus (A/PR/8/34) and studied their expression in HEK293 cells.HA andHA₁ genes were amplified by RT-PCR and cloned into pcDNA3. 1(+) to generate pcDNA3. 1(+)/HA and pcDNA3.1(+)/HA₁, respectively. After verification of the cloning fidelity by restriction endonuclease digestion, PCR, and sequencing, pcDNA3. 1(+)/HA and pcDNA3.1(+)/HA₁ were transfected into HEK293 cells using PolyFect Transfection Reagent. Immunofluorescence assay was used to detect the transient expressing cells. Fluorescence microscopy revealed strong expression of target gene in HEK293 cells transiently transfected with either pcDNA3.1(+)/HA or pcDNA3.1(+)/HA₁. Therefore, the results confirm the successful construction of eukaryotic expressing plasmids capable of driving the eukaryotic expression of influenza virus antigen HA and HA₁, which is likely to provide a basis for both further investigation of the mechanism of influenza viral infection and the development of influenza DNA vaccine.

Keywords

influenza virus / haemagglutinin / pcDNA3.1(+) / immunofluorescence assay

References

[1] DonnellyJ J, UlmerJ B, ShiverJ W, et al. . DNA vaccine. Annu Rev Immunol, 1997, 15: 617-648

[2] TigheH, CorrM, RomanM, et al. . Gene vaccination: plasmid DNA is more than just a blueprint. Immunol Today, 1998, 19(2): 89-97

[3] WinterG, FieldsS, BrownleetG G. Nucleotide sequence of the haemagglutinin gene of a human influenza virus H1 subtype. Nature, 1981, 292(2): 72-75

[4] ZhangQ Z, QinX M, LiangR, et al. . Construction and Expression of avian influenza virusHA gene eukaryotic vectors. Prog Biochem Biophys, 2003, 30(3): 483-486

[5] RobinsonH L, HuntL A, WebsterR G. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine, 1993, 11(9): 9571-960

[6] ConstantinB, DorelR, KoderaT. Molecular studies on the diversification of haemagglutinin-specific human neonatal repertoire subsequent to immunization with naked NDA. Vaccine, 2004, 22: 1624-1630